GC
GPCR icon

Gilbert & Cook’s Structure Therapeutics GPCR Stock Holding History

Gilbert & Cook’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443K Buy
9,193
+3,511
+62% +$240K 0.06% 157
2025
Q4 		$395K Buy
+5,682
New +$232K 0.05% 171
2024
Q4 		– Sell
-5,682
Closed -$249K – 206
2024
Q3 		$249K Sell
5,682
-148
-3% -$5.72K 0.03% 195
2024
Q2 		$229K Buy
+5,830
New +$239K 0.03% 197

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Gilbert & Cook's GPCR Position: Q1 2026 in Review

Gilbert & Cook increased its Structure Therapeutics (GPCR) stake by 62% in Q1 2026, buying an estimated $240K and bringing the position to 9,193 shares worth $443K. The position accounts for 0.06% of the portfolio, ranked #157.

Gilbert & Cook first reported a position in GPCR in Q2 2024 and has held it in 4 quarters since. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Gilbert & Cook held 9,193 shares of Structure Therapeutics worth $443K as of Q1 2026.
  • Gilbert & Cook bought 3,511 Structure Therapeutics shares in Q1 2026, an estimated $240K.
  • Structure Therapeutics made up 0.06% of Gilbert & Cook's portfolio in Q1 2026, its #157 holding.
  • Gilbert & Cook first reported a position in Structure Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Gilbert & Cook's 13F filing for Q1 2026, filed 5 May 2026.